Concepedia

Prediction of the tacrolimus population pharmacokinetic parameters according to CYP3A5 genotype and clinical factors using NONMEM in adult kidney transplant recipients

Nayoung Han, Hwi‐yeol Yun, Jin-yi Hong, In‐Wha Kim, Eunhee Ji, Su Hyun Hong, Yon Su Kim, Jongwon Ha, Wan Gyoon Shin, Jung Mi Oh

European Journal of Clinical Pharmacology · 2012 · 73 citations · 31 references

DOI

Concepts

References

31

Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression

Peter Kuehl, Jiong Zhang, Yvonne Lin et al. · Nature Genetics · 2001 · 2.2K citations

, , +14

The genetic determinants of the CYP3A5 polymorphism

Elisabeth Hustert, Michael Haberl, Oliver Burk et al. · Pharmacogenetics · 2001 · 670 citations

Genetic polymorphisms of the CYP3A4, CYP3A5, and MDR-1 genes and pharmacokinetics of the calcineurin inhibitors cyclosporine and tacrolimus

Dennis A. Hesselink · Clinical Pharmacology & Therapeutics · 2003 · 654 citations

The effect of CYP3A5 and MDR1 (ABCB1) polymorphisms on cyclosporine and tacrolimus dose requirements and trough blood levels in stable renal transplant patients

Vincent Haufroid, Michel Mourad, Val rie Van Kerckhove et al. · Pharmacogenetics · 2004 · 444 citations

, , +11

Interindividual Variability and Tissue-Specificity in the Expression of Cytochrome P450 3A mRNA

Ina Koch, Regina Weil, Renzo Wolbold et al. · Drug Metabolism and Disposition · 2002 · 313 citations